3-Oxo-4-(?D-ribofuranosyl)-3,4-dihydro-2-pyrazinecarboxamide

Modify Date: 2024-01-24 15:39:23

3-Oxo-4-(?D-ribofuranosyl)-3,4-dihydro-2-pyrazinecarboxamide Structure
3-Oxo-4-(?D-ribofuranosyl)-3,4-dihydro-2-pyrazinecarboxamide structure
Common Name 3-Oxo-4-(?D-ribofuranosyl)-3,4-dihydro-2-pyrazinecarboxamide
CAS Number 356782-84-8 Molecular Weight 271.23
Density N/A Boiling Point N/A
Molecular Formula C10H13N3O6 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of 3-Oxo-4-(?D-ribofuranosyl)-3,4-dihydro-2-pyrazinecarboxamide


3,4-Dihydro-3-oxo-4-β-D-ribofuranosyl-2-pyrazinecarboxamide is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

 Names

Name 3,4-dihydro-3-oxo-4-β-D-ribofuranosyl-2-pyrazinecarboxaMide

  Biological Activity

Description 3,4-Dihydro-3-oxo-4-β-D-ribofuranosyl-2-pyrazinecarboxamide is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Related Catalog
References

[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.  

 Chemical & Physical Properties

Molecular Formula C10H13N3O6
Molecular Weight 271.23